158 related articles for article (PubMed ID: 21473913)
1. Challenges in diagnosing acute calcineurin-inhibitor induced nephrotoxicity: from toxicogenomics to emerging biomarkers.
Pallet N; Djamali A; Legendre C
Pharmacol Res; 2011 Jul; 64(1):25-30. PubMed ID: 21473913
[TBL] [Abstract][Full Text] [Related]
2. A comparative study on renal biopsy before and after long-term calcineurin inhibitors therapy: an insight for pathogenesis of its toxicity.
Singh L; Singh G; Sharma A; Sinha A; Bagga A; Dinda AK
Hum Pathol; 2015 Jan; 46(1):34-9. PubMed ID: 25449629
[TBL] [Abstract][Full Text] [Related]
3. Deciphering calcineurin inhibitor nephrotoxicity: a pharmacological approach.
Pallet N; Legendre C
Pharmacogenomics; 2010 Oct; 11(10):1491-501. PubMed ID: 21047207
[TBL] [Abstract][Full Text] [Related]
4. [Nephrotoxicity of calcineurin inhibitors: presentation, diagnostic problems and risk factors].
Snanoudj R; Rabant M; Royal V; Pallet N; Noël LH; Legendre C
Nephrol Ther; 2009 Dec; 5 Suppl 6():S365-70. PubMed ID: 20129447
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of calcineurin inhibitor nephrotoxicity in transplantation.
Fernando M; Peake PW; Endre ZH
Biomark Med; 2014; 8(10):1247-62. PubMed ID: 25525985
[TBL] [Abstract][Full Text] [Related]
6. The pharmacogenetics of calcineurin inhibitor-related nephrotoxicity.
Hesselink DA; Bouamar R; van Gelder T
Ther Drug Monit; 2010 Aug; 32(4):387-93. PubMed ID: 20571464
[TBL] [Abstract][Full Text] [Related]
7. Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?
Wali RK; Weir MR
Curr Opin Organ Transplant; 2008 Dec; 13(6):614-21. PubMed ID: 19060552
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension.
Hošková L; Málek I; Kopkan L; Kautzner J
Physiol Res; 2017 May; 66(2):167-180. PubMed ID: 27982677
[TBL] [Abstract][Full Text] [Related]
9. [Monitoring of calcineurin inhibitors induced-nephrotoxicity].
Kamar N; Rostaing L
Nephrol Ther; 2008 Jun; 4 Suppl 1():S13-S17. PubMed ID: 18703392
[TBL] [Abstract][Full Text] [Related]
10. Calcineurin inhibitors and nephrotoxicity in children.
Liu F; Mao JH
World J Pediatr; 2018 Apr; 14(2):121-126. PubMed ID: 29532435
[TBL] [Abstract][Full Text] [Related]
11. Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts.
Liptak P; Ivanyi B
Nat Clin Pract Nephrol; 2006 Jul; 2(7):398-404; quiz following 404. PubMed ID: 16932468
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence.
Issa N; Kukla A; Ibrahim HN
Am J Nephrol; 2013; 37(6):602-12. PubMed ID: 23796509
[TBL] [Abstract][Full Text] [Related]
13. CD44 as a pathological marker for the early detection of calcineurin inhibitor-induced nephrotoxicity post kidney transplantation.
Hayashi A; Okamoto T; Nio-Kobayashi J; Iwahara N; Suzuki R; Ueda Y; Takahashi T; Yasuyuki Sato ; Iwanaga T; Hotta K
Biomed Res; 2022; 43(5):181-186. PubMed ID: 36244796
[TBL] [Abstract][Full Text] [Related]
14. Is arteriolar vacuolization a predictor of calcineurin inhibitor nephrotoxicity?
Horike K; Takeda A; Yamaguchi Y; Ogiyama Y; Yamauchi Y; Murata M; Kawaguchi T; Suzuki T; Otsuka Y; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
Clin Transplant; 2011 Jul; 25 Suppl 23():23-7. PubMed ID: 21623910
[TBL] [Abstract][Full Text] [Related]
15. Fascin-1 is released from proximal tubular cells in response to calcineurin inhibitors (CNIs) and correlates with isometric vacuolization in kidney transplanted patients.
Jacobs-Cachá C; Torres IB; López-Hellín J; Cantarell C; Azancot MA; Román A; Moreso F; Serón D; Meseguer A; Sarró E
Am J Transl Res; 2017; 9(9):4173-4183. PubMed ID: 28979691
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinicopathological impact of calcineurin inhibitor cessation without specific cytoreductive induction in kidney transplantation.
Tanabe T; Morita K; Fujita H; Hatanaka K; Ogawa Y; Hirose T; Sasaki H; Iwami D; Hotta K; Nonomura K
Clin Transplant; 2013; 27 Suppl 26():9-13. PubMed ID: 24299230
[TBL] [Abstract][Full Text] [Related]
17. New strategies to reduce nephrotoxicity.
Kreis H
Transplantation; 2001 Dec; 72(12 Suppl):S99-104. PubMed ID: 11833149
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity.
Kushwaha SS; Khalpey Z; Frantz RP; Rodeheffer RJ; Clavell AL; Daly RC; McGregor CG; Edwards BS
J Heart Lung Transplant; 2005 Dec; 24(12):2129-36. PubMed ID: 16364861
[TBL] [Abstract][Full Text] [Related]
19. Supplementation with omega-3 polyunsaturated fatty acids and experimental tacrolimus-induced nephrotoxicity.
Fernandes MB; Caldas HC; Toloni LD; Baptista MA; Fernandes IM; Abbud-Filho M
Exp Clin Transplant; 2014 Dec; 12(6):522-7. PubMed ID: 25489802
[TBL] [Abstract][Full Text] [Related]
20. Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation.
Helal I; Chan L
Transplant Proc; 2011 Mar; 43(2):472-7. PubMed ID: 21440737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
